Home
About
Team
Portfolio
News
Contact Us
2024-11-13
Pulmatrix and Cullgen Announce Proposed Merger
Pulmatrix and Cullgen have announced a merger to form a Nasdaq-listed entity, focusing on targeted protein degradation
2024-11-13
BioNTech to Acquire China’s Biotheus for USD800 Million
BioNTech has reached an agreement to acquire Chinese biopharmaceutical company Biotheus for $800 million
2024-11-12
HLC Brings Healthcare Portfolio Companies to Southeast Asia
HLC team, along with our portfolio companies and ecosystem partners, embarked on a 5-day business development trip to Thailand and Indonesia.
2024-10-08
HighLight Capital invests in ITM
HLC invests in ITM to support ITM's radiopharmaceutical pipeline and to strengthen its leading position in medical radioisotope manufacturing.
2024-09-18
HLC Achieves Top Rankings in Preqin
HighLight Capital achieves outstanding performance in net IRR and DPI.
2024-05-09
HLC Ranks Top 20 in the HEC Paris – Dow Jones 2023 Growth Capital Performance Ranking
HLC ranked as Top 20 and was one of the only three Asian firm that entered the list.
1
2
3
4
5
25 records in total